Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
90
days
Remibrutinib impact on disease control, sleep, and quality of life
AuthorsGiselle Mosnaim; Sarbjit Saini; Mark Lebwohl; Simon F. Thomsen; John Reed; Bin Yang; Atsushi Fukunaga; Vipul Jain; Clarice Field; Merin Kuruvilla; El-Djouher Martzloff; Noriko Seko; Pengpeng Wang; Sibylle Haemmerle; Martin Metz
AffiliationsDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, Illinois; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Dermato-Venereology and Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Dermatology, Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, United Kingdom; Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangdong Provincial People’s Hospital, Guangzhou, People's Republic of China; Department of Dermatology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan; Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada; Novartis Ireland Limited, Dublin, Ireland; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma K.K., Tokyo, Japan; Novartis (China) Biomedical Research, Shanghai, People's Republic of China; Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Immunology and Allergology, Berlin, Germany
97
days
Unique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease
AuthorsDante G. Minichetti; Tiffany Dharia; Amelia Boyd; Alyson Brown; Alexander Perniss; Evan Lemire; Adam L. Haber; Rachel E. Roditi; Stella E. Lee; Valentina Parma; Kathleen M. Buchheit; Tanya M. Laidlaw; Lora G. Bankova
AffiliationsDivision of Allergy and Clinical Immunology, Jeff and Penny Vinik Center for Allergic Disease Research, Brigham and Women’s Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women’s Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston, Massachusetts; Monell Chemical Senses Center, Philadelphia, Pennsylvania
46
days
Clinician and family perspectives on the use of single maintenance and reliever therapy for children
AuthorsElika Eshghi; Grace Ryan; Melissa Goulding; Michelle Spano; Stephanie Simms; Deicy Mejia; Hannah Seay; Anna Bryce; Lynn B. Gerald; Anna Bottar; Nancy Byatt; Jerry A. Krishnan; Christine Frisard; Stephenie C. Lemon; Sybil Crawford; Radley Sheldrick; Lori Pbert; Michelle Trivedi
AffiliationsDivision of Pulmonary Medicine, Department of Pediatrics, University of Massachusetts (UMass) Chan Medical School, UMass Memorial Children’s Medical Center, Worcester, Massachusetts; Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts; Department of Pediatric Pulmonology, Mass General Brigham for Children, Boston, Massachusetts; Office of Population Health Sciences, University of Illinois Chicago, Chicago, Illinois; Department of Pediatrics, UMass Memorial Children’s Medical Center, Worcester, Massachusetts; Lifeline for Families, Department of Psychiatry, UMass Chan Medical School, Worcester, Massachusetts; Department of Obstetrics and Gynecology, UMass Chan Medical School, Worcester, Massachusetts; Breathe Chicago Center, University of Illinois Chicago, Chicago, Illinois; Tan Chingfen Graduate School of Nursing, UMass Chan Medical School, Worcester, Massachusetts; Department of Psychiatry and Behavioral Sciences, UMass Chan Medical School, Worcester, Massachusetts; Child Health Equity Center, Department of Pediatrics, UMass Chan Medical School, UMass Memorial Children’s Medical Center, Worcester, Massachusetts
120
days
Co-occurrence of bronchiectasis among patients with chronic rhinosinusitis based on associated asthma
AuthorsChristopher Bougher; Dhvanii Raval; Sherron Thomas; Rami Abuqubo; Xin Wang; Christina H. Fang; Nadeem Akbar; Golda Hudes; Denisa Ferastraoaru
AffiliationsAlbert Einstein College of Medicine, Bronx, NY, USA; Department of Otorhinolaryngology, Montefiore Medical Center, Bronx, NY, USA; Department of Allergy & Immunology, Montefiore Medical Center, Bronx, NY, USA
67
days
Adult-Onset atypical food protein-induced enterocolitis syndrome after chemotherapy: A case report
AuthorsKristina M Brown; Mariel Benjamin
AffiliationsDivision of Allergy and Immunology, University of Michigan, Ann Arbor, Michigan
253
days
Improved asthma outcomes with dupilumab plus medium-dose inhaled corticosteroids vs placebo plus high-dose inhaled corticosteroids
AuthorsWilliam W. Busse; Mario Castro; Njira L. Lugogo; Paul M. O’Byrne; Leonard B. Bacharier; Changming Xia; Olivier Ledanois; Mena Soliman
AffiliationsUniversity of Wisconsin Allergy, Pulmonary, and Critical Care Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; Department of Medicine, School of Medicine, University of Kansas, Kansas City, Kansas; Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, Michigan; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Division of Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr Children’s Hospital at Vanderbilt University Medical Center, Nashville, Tennessee; Regeneron Pharmaceuticals Inc, Tarrytown, New York; Sanofi, Paris, France
101
days
Depemokimab reduces asthma exacerbations similarly to other biologics
AuthorsArnaud Bourdin; Ian D. Pavord; Nicholas Ballew; Brandon Butcher; Lydia Vinals; Houcine El Alili; Vikas Jangra; Victor Laliman-Khara; Grammati Sarri; Anna Vichiendilokkul; Peter Howarth; Rafael Alfonso-Cristancho
AffiliationsDepartment of Pulmonology and Addictology, PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier, France; Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Global Data Generation, GSK, Collegeville, Pennsylvania; Clinical Sciences – Respiratory, GSK, Philadelphia, Pennsylvania; Cytel, Montreal, Québec, Canada; Cytel, Rotterdam, The Netherlands; Cytel, Calgary, Alberta, Canada; Department of RWA Health Economics, Cytel, Waltham, Massachusetts; Cytel, London, United Kingdom; Global Medical Affairs, GSK, Collegeville, Pennsylvania; Global Medical Affairs, Respiratory Specialty Care, GSK, London, United Kingdom; Global Real World Evidence and Health Outcomes, GSK, Collegeville, Pennsylvania
146
days
Predictors of psychosocial burden in parents of children with food allergy
AuthorsStephanie A. Kubala; Fernanda D. Young; Viviane Callier; Marjohn M. Rasooly; Caeden Dempsey; Allyson Mateja; Erica Brittain; Pamela A. Frischmeyer-Guerrerio
AffiliationsFood Allergy Research Section, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, North Bethesda, Maryland
24
days
Utility of exhaled nitric oxide as a potential biomarker for multiple food allergies in patients without asthma
AuthorsMiguel J. Lanz; Lianet Herrera Cespedes; Esther M. Chartrand; Claudia P. Eisenlohr
AffiliationsAllergy Asthma Atopic Dermatitis Rhinosinusitis (AAADRS) Clinical Research Center, Coral Gables, Florida
49
days
Enhanced clinical decision-making to optimize targeted gene panel testing for inborn errors of immunity
AuthorsNatsumon Udomkittivorakul; Jiahua Zhang; Jyoti Arora; Lance W. Peterson; Tarin M. Bigley; Erica G. Schmitt; Megan A. Cooper; Maleewan Kitcharoensakkul
AffiliationsDivision of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri; Division of Hospital Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri; Division of Biostatistics, Washington University School of Medicine, Saint Louis, Missouri; Division of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days